山羊抗小鼠IgG H&L (APC)预吸附二抗(ab130782)
Key features and details
- Goat Anti-Mouse IgG H&L (APC) preadsorbed
- Conjugation: APC. Ex: 645nm, Em: 660nm
- Host species: Goat
- Isotype: IgG
- Suitable for: ICC/IF, ELISA, WB
Related conjugates and formulations
概述
-
产品名称
山羊抗小鼠IgG H&L (APC)预吸附二抗
参阅全部 IgG 二抗 -
宿主
Goat -
靶标种属
Mouse -
特异性
ab130782 reacts with the heavy and light chains of mouse IgG1, IgG2a, IgG2b and IgG3 and with the light chains of mouse IgM and IgA as demonstrated by ELISA, FLISA, and flow cytometry. Goat Anti-Mouse IgG H&L (Allophycocyanin) preadsorbed exhibits minimal cross reactivity with Human immunoglobulins.
-
经测试应用
适用于: ICC/IF, ELISA, WBmore details -
最小交叉反应
Human more details -
免疫原
Mouse IgG paraproteins
-
偶联物
APC. Ex: 645nm, Em: 660nm
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. Store In the Dark. -
存储溶液
pH: 7.3
Preservative: 0.1% Sodium azide
Constituents: PBS, Sucrose -
Concentration information loading...
-
纯化说明
ab130782 was purified by affinity chromatography on pooled Mouse IgG covalently linked to agarose. -
克隆
多克隆 -
同种型
IgG -
常规说明
ab130782 is cross absorbed against pooled Human sera and purified Human paraproteins. -
研究领域
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab130782于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
ICC/IF |
Use 0.1µg for 106 cells.
|
|
ELISA |
Use at an assay dependent concentration.
|
|
WB |
Use at an assay dependent concentration.
|
说明 |
---|
ICC/IF
Use 0.1µg for 106 cells. |
ELISA
Use at an assay dependent concentration. |
WB
Use at an assay dependent concentration. |
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (2)
ab130782 被引用在 2 文献中.
- Yuan X et al. Rhein enhances the cytotoxicity of effector lymphocytes in colon cancer under hypoxic conditions. Exp Ther Med 16:5350-5358 (2018). PubMed: 30542494
- Zhang Q et al. Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells. Int J Cancer 141:1445-1457 (2017). PubMed: 28643325